BINDING OF RETELLIPTINE, A NEW ANTITUMORAL AGENT, TO SERUM-PROTEINS AND ERYTHROCYTES

被引：14

作者：

MAULARD, C ^{[1
]}

URIEN, S ^{[1
]}

BASTIAN, G ^{[1
]}

TILLEMENT, JP ^{[1
]}

机构：

[1] FAC MED CRETEIL,PHARMACOL LAB,F-94010 CRETEIL,FRANCE

来源：

BIOCHEMICAL PHARMACOLOGY | 1990年 / 40卷 / 04期

基金：

美国国家卫生研究院;

关键词：

D O I：

10.1016/0006-2952(90)90333-G

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

[No abstract available]

引用

页码：895 / 898

页数：4

共 14 条

[1]

ATASSI G, 1989, P ASCO

[2] POTENTIAL ANTITUMOR AGENTS .50. INVIVO SOLID-TUMOR ACTIVITY OF DERIVATIVES OF N-[2-(DIMETHYLAMINO)ETHYL]ACRIDINE-4-CARBOXAMIDE [J].

ATWELL, GJ ;

REWCASTLE, GW ;

BAGULEY, BC ;

DENNY, WA .

JOURNAL OF MEDICINAL CHEMISTRY, 1987, 30 (04) :664-669

[3]

AUCLAIR C, 1987, CANCER RES, V47, P6254

[4] EFFECT OF MEMBRANE-POTENTIAL ON THE CELLULAR UPTAKE OF 2-N-METHYL-ELLIPTICINIUM BY L1210-CELLS [J].

CHARCOSSET, JY ;

JACQUEMINSABLON, A ;

LEPECQ, JB .

BIOCHEMICAL PHARMACOLOGY, 1984, 33 (14) :2271-2275

[5] OPTICAL STUDIES ON THE SPECIFIC INTERACTION OF DIPYRIDAMOLE WITH ALPHA-1-ACID GLYCOPROTEIN (OROSOMUCOID) [J].

ELGAMEL, S ;

WOLLERT, U ;

MULLER, WE .

JOURNAL OF PHARMACY AND PHARMACOLOGY, 1982, 34 (03) :152-157

[6]

ELMASHAK ESM, 1980, EUR J BIOCHEM, V105, P593

[7]

KOHN KW, 1975, CANCER RES, V35, P71

[8]

PAXTON JW, 1983, METHOD FIND EXP CLIN, V5, P635

[9] INTERRELATIONSHIP BETWEEN AFFINITY FOR DNA, CYTO-TOXICITY AND INDUCTION OF DNA-BREAKS IN CULTURED L1210-CELLS FOR 2 SERIES OF TRICYCLIC INTERCALATORS - SIMPLIFIED ANALOGS OF ELLIPTICINE DERIVATIVES [J].

PIERSON, V ;

PIERRE, A ;

DECOINTET, P ;

NGUYEN, CH ;

BISAGNI, E ;

GROS, P .

BIOCHEMICAL PHARMACOLOGY, 1989, 38 (09) :1395-1406

[10] PREPARATION OF LOW-DENSITY LIPOPROTEIN-9-METHOXYELLIPTICIN COMPLEX AND ITS CYTO-TOXIC EFFECT AGAINST L1210 AND P388 LEUKEMIC-CELLS INVITRO [J].

SAMADIBABOLI, M ;

FAVRE, G ;

BLANCY, E ;

SOULA, G .

EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1989, 25 (02) :233-241

← 1 2 →